2025-521962-83-00招募中2 期
AdaptNK –Cell Therapy for High-risk Myeloid Disease
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 26
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Karl-Johan Malmberg
Scientific
Karolinska Institutet
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
1 期
Exploratory Clinical Study on Memory NK Cell Therapy for Advanced Metastatic Solid TumorsNCT07274449The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School6
招募中
1 期
Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin LymphomaNCT07283679M.D. Anderson Cancer Center30
尚未招募
2 期
Clinical Study on Maintenance Therapy With Selinexor Combined With Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for NK/T-cell LymphomaNCT07276698Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine39
招募中
2 期
Clinical trial of infusion of activated NK cells for the treatment of children, adolescents and young adults with sarcomas.2024-513431-25-00Hospital Universitario La Paz, Hospital Universitario La Paz10
招募中
2 期
AML-NET : Acute Myeloid Leukemia treated with with NETrin Abs in combination with [AZACITIDINE + VENETOCLAX]2023-503408-10-00Centre Leon Berard, Centre Leon Berard35